Lista de obras -

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

artículo científico publicado en 2017

Atherosclerotic Disease of the Aortic Arch and the Risk of Ischemic Stroke

article published in 1994

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

artículo científico

Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.

artículo científico publicado en 2018

Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.

artículo científico

Concurrent dolichoectasia of basilar and coronary arteries

artículo científico publicado en 2005

Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial

artículo científico publicado en 2019

Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular E

artículo científico publicado en 2016

Five-year prognosis after TIA or minor ischemic stroke in Asian and non-Asian countries

artículo científico publicado en 2020

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

artículo científico publicado en 2014

Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansie

artículo científico publicado el 22 de mayo de 2013

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis

artículo científico publicado en 2013

Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab

artículo científico publicado en 2017

Lipoprotein(a) as a cardiovascular risk factor: current status

artículo científico publicado en 2010

Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke

artículo científico publicado en 2011

New prospects for PCSK9 inhibition?

artículo científico publicado en 2018

Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM study.

artículo científico publicado en 2018

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke

artículo científico publicado en 2016

Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke

artículo científico publicado en 2016

Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease

artículo científico publicado en 2003

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

article

Recommendations for the Implementation of Telemedicine Within Stroke Systems of Care

scientific article published on 07 May 2009

Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial).

artículo científico publicado en 2008

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

article published in 2018

Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial

article

Specificities of Ischemic Stroke Risk Factors in Arab-Speaking Countries

artículo científico publicado en 2017

Stroke research priorities for the next decade--A representative view of the European scientific community

artículo científico publicado en 2006

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

scientific article published in The Lancet

The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design

artículo científico publicado en 2019

The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet Treatment

artículo científico publicado en 2017

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

artículo científico publicado en 2015

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction

scientific article published on 04 June 2019

Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA

artículo científico publicado en 2020

Transient Ischemic Attack

scientific article published on 01 May 2020

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management ⬇️

artículo científico publicado en 2011

Twelve-month outcome in patients with stroke and atrial fibrillation not suitable to oral anticoagulant strategy: the WATCH-AF registry

artículo científico publicado en 2019

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials

artículo científico publicado en 2014

Lista de obras de

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

Atherosclerotic Disease of the Aortic Arch and the Risk of Ischemic Stroke

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.

Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.

Concurrent dolichoectasia of basilar and coronary arteries

Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial

Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular E

Five-year prognosis after TIA or minor ischemic stroke in Asian and non-Asian countries

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansie

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis

Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab

Lipoprotein(a) as a cardiovascular risk factor: current status

Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke

New prospects for PCSK9 inhibition?

Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM study.

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke

Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke

Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

Recommendations for the Implementation of Telemedicine Within Stroke Systems of Care

Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial).

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial

Specificities of Ischemic Stroke Risk Factors in Arab-Speaking Countries

Stroke research priorities for the next decade--A representative view of the European scientific community

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design

The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet Treatment

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction

Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA

Transient Ischemic Attack

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management ⬇️

Twelve-month outcome in patients with stroke and atrial fibrillation not suitable to oral anticoagulant strategy: the WATCH-AF registry

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials